MOSCOW, April 2 – RIA Novosti. Post-registration studies of the Sputnik V vaccine will be completed by about mid-June, after which the report will be handed over to experts of the Ministry of Health, who must make a decision on permanent registration of the vaccine, director of the Gamaleya Research Center for Epidemiology and Microbiology of the Ministry of Health of Russia Alexander Gintsburg told RIA Novosti.
“Observations are now going on for six months, we need to observe long-term consequences, and as if it were mid-June, give us another two or three weeks for this – to sign the report and submit it to the expert institution of the Ministry of Health, and after that, I hope, a decision will be made on permanent registration, “he said.
At the same time, Gunzburg noted that there would be no fundamental changes in the instructions after the completion of the tests.
In August 2020, the Ministry of Health of Russia registered the world's first vaccine for the prevention of COVID-19, developed by the Gamaleya Research Center for Electrochemistry. It was named “Sputnik V”. The vaccine is based on a well-studied and validated human adenoviral vector platform, the important benefits of which are safety, efficacy and no long-term adverse effects. Currently, the drug is undergoing post-registration tests.
Also in Russia, two more vaccines against COVID-19 have been created – this is a vaccine from the Vector Center of Rospotrebnadzor EpiVacCorona and the KoviVac vaccine developed by the Chumakov Center of the Russian Academy of Sciences.